The U.S. Department of Energy (DoE) highlighted potential applications of Actinium-225 (225Ac) in treating prostate cancer in 2018, opening a new era of alpha emitter-based targeted therapy. Alpha particle emitter, 225Ac has high linear energy transf...
|SIXIANG SHI (Project Owner)
|School of Medicine, Radiology Research
|College of Pharmacy, Molecular Pharmaceutics
|College of Engineering, Civil And Environmental Engg